ArticleSecond-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Single Institution Experience
ArticleSecond-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Single Institution Experience
ArticleEvaluation of Concurrent Adjuvant Chemotherapy Paclitaxel and Radiotherapy in Breast Conserving Management of Early Breast Cancer
ArticleEvaluation of Concurrent Adjuvant Chemotherapy Paclitaxel and Radiotherapy in Breast Conserving Management of Early Breast Cancer
ArticlePrognostic Factors for Platinum-Chemotherapy Response and Survival Outcomes in Patients with Advanced Stage Non-Small Cell Lung Cancer
ArticlePrognostic Factors for Platinum-Chemotherapy Response and Survival Outcomes in Patients with Advanced Stage Non-Small Cell Lung Cancer
ArticleCONCURRENT CHEMO-RADIOTHERAPY OF WEEKLY PACLITAXEL VERSUS WEEKLY CARBOPLATIN IN LOCALLY ADVANCED HEAD AND NECK CARCINOMAS UNFIT FOR CISPLATIN
ArticleCONCURRENT CHEMO-RADIOTHERAPY OF WEEKLY PACLITAXEL VERSUS WEEKLY CARBOPLATIN IN LOCALLY ADVANCED HEAD AND NECK CARCINOMAS UNFIT FOR CISPLATIN
ArticleNavigating the Intricacies of Breast Cancer Histological Terrain and the Efficacy of Paclitaxel as a Chemotherapeutic Arsenal
ArticleNavigating the Intricacies of Breast Cancer Histological Terrain and the Efficacy of Paclitaxel as a Chemotherapeutic Arsenal
ArticleEffect of neoadjuvant chemotherapy on circulating immune cells in breast cancer patients: A pilot study
ArticleEffect of neoadjuvant chemotherapy on circulating immune cells in breast cancer patients: A pilot study
ThesisStudy of induction paclitaxel and cisplatin followed by standard radiotherapy vs hyper fractionated radiotherapy and cisplatin as radio sensitizer for patients with unresectable stage IIIA and IIIB non-small cell lung cancer
ThesisStudy of induction paclitaxel and cisplatin followed by standard radiotherapy vs hyper fractionated radiotherapy and cisplatin as radio sensitizer for patients with unresectable stage IIIA and IIIB non-small cell lung cancer